Navigation Links
AMIA Announces 2008 Summit on Translational Bioinformatics

ll focus on the topic of translational bioinformatics, is a clear indicator of the Association's strong commitment to serve as the professional home for practitioners in this domain and as a premier venue for reporting advances in the state of translational research."

The summit will take place March 12-15, 2008 at the Hilton San Francisco in San Francisco, California. A call for participation and program will be announced in the near future. For more information about AMIA's translational bioinformatics activities, visit the AMIA web site at: http://www.amia.org.

    Contact:  Tia Abner

              301-657-1291 ext. 105
tia@amia.org

About AMIA

The American Medical Informatics Association (AMIA) is a professional organization of leaders shaping the future of biomedical and health informatics in the United States and over 50 other nations. AMIA is dedicated to the development and application of informatics in support of patient care, public health, teaching, research, administration, and related policy. Complete information about AMIA is available at: http://www.amia.org.

CONTACT: Tia Abner of American Medical Informatics Association,+1-301-657-1291 ext. 105, tia@amia.org

Web site: http://www.amia.org/

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: AMIA Announces Summit Translational Bioinformatics
(Date:12/1/2008)...tCall/ -- GeoVax Labs, Inc.,(OTC Bulletin Board: ...loping,human vaccines for diseases caused by HIV-...ious agents, announced today that the launch of it...n twelve sites across North and South America.,Th... National Institutes of,Health (NIH), and the HIV...
(Date:11/28/2008)...28 German biotech company,Partec ...HIV monitoring and,AIDS patient follow-up diagnos...e year 2008, 2.5 million patient tests have been p...ordable "CyFlow" system, supporting already,more ... introduction of the,Partec innovation, the avera...
(Date:11/26/2008)...utomation and intelligent clinical applications ta... level , , CHICAGO, Ill., Nov. 26 /PRNewswi...ens.com/healthcare ) highlights the ACUSON S2000(...e world,s first multi-use, automated volume breast...y and Annual Meeting of the Radiological Society o...
(Date:11/25/2008)...against expanding statin use broadly in wake of AH...ov. 25 JUPITER, a clinical trial s...r risk of healthy patients with elevated CRP, shou..., according to a national poll directed at health ...n the online poll conducted by medical news site M...
Breaking Medicine Technology:GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2Siemens Introduces New Standard of Care for Breast Ultrasound 2Siemens Introduces New Standard of Care for Breast Ultrasound 3Siemens Introduces New Standard of Care for Breast Ultrasound 4Siemens Introduces New Standard of Care for Breast Ultrasound 5Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 3Nearly Half of Newly Diagnosed HIV AIDS Cases in Los Angeles County Are Among Latinos 27301 1Nearly Half of Newly Diagnosed HIV AIDS Cases in Los Angeles County Are Among Latinos 27301 2Vista Partners Updates Coverage on Arana Therapeutics 28ASX 3A AAH 3B AIM 3A AAHx 29 Raises Target Price to AU 241 65 8239 1Vista Partners Updates Coverage on Arana Therapeutics 28ASX 3A AAH 3B AIM 3A AAHx 29 Raises Target Price to AU 241 65 8239 2Excess Drinking Shrinks the Brain 27296 1Excess Drinking Shrinks the Brain 27296 23 Michigan Counties Participating in NIH Study of Cardiac Arrest Resuscitation Techniques 27293 13 Michigan Counties Participating in NIH Study of Cardiac Arrest Resuscitation Techniques 27293 2
...-Jun 7, 2007 - Clinical results from a,Phase II st...eadache Society (AHS) annual meeting showed that M...lated peptide (CGRP),receptor antagonist, signific...r dosing compared to placebo, and the relief was,s...ell tolerated in,the study. Responses specific to ...
...07, 2007 /PRNewswire-FirstCall/ --,Mymetics Corpor...ating that the Company,s HIV vaccine elicited neut...mate model. Mucosal IgA,antibodies are considered ...ion by HIV. The data were presented by Sylvain,Fle... an oral,presentation titled, "Without Mucosal Adj...
Other Medicine Technology:Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 2Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 3Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 4Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 5Mymetics' HIV Vaccine Demonstrates First-Ever Production of,Neutralizing IgA Antibodies in Non-Human Primate Model 2Mymetics' HIV Vaccine Demonstrates First-Ever Production of,Neutralizing IgA Antibodies in Non-Human Primate Model 3Mymetics' HIV Vaccine Demonstrates First-Ever Production of,Neutralizing IgA Antibodies in Non-Human Primate Model 4
(Date:12/1/2008)...lergy Friendly, Toy Puppies to the Obama Daughters...ire/ -- Much has been made of President-Elect Obam...rns about his daughter,s asthma and allergies, and...aking a decision. So, in the meantime, the Asthma...ing 2 "asthma & allergy friendly" toy puppies ...
(Date:12/1/2008)...und that the availability of a portable eight-slic... room can significantly increase the number of str...treatment. Results of the study, conducted at Nort...lem, Mass., will be presented today at the annual ...ca (RSNA). , "The hospital,s acquisition of a p...
(Date:12/1/2008)...s that computed tomography (CT) colonography, also...o screen for two diseases at oncecolorectal cancer...dults over age 50. Results of the study will be pr...gical Society of North America (RSNA). , "With C...ectal cancer, we were able to identify patients wi...
(Date:12/1/2008)... As the connection between second-hand smoke and c...islation was passed to reduce such passive smoking...shed in the January 2009 issue of the American Jo...e University of California, San Francisco, Partner...recalibrated the CHD Policy Model to better predic...
Breaking Medicine News(10 mins):Health News:Asthma and Allergy Foundation Helps New First-Dad Keep His First Promise 2Health News:Portable CT increases chance of stroke survival and recovery 2Health News:CT colonography offers 1-stop screening for cancer and osteoporosis 2
...ommonwealth University Massey Cancer Center have d...ns, using small molecules containing platinum, whi...l be beneficial for the researchers to develop new...cer by selectively targeting proteins known as zin...
...-run hospitals across the country were restored to...nti-quota protests following a directive from the ...institutions like AIIMS, MAMC, Lady Hardinge and S...ioning with junior doctors reporting back to duty....
...ve found that an amphetamine-like stimulant has a ...hyperactivity disorder (ADHD) // . A new study un... a drug that is widely used to treat ADHD, appears...sn't as easily distracted by any stimuli from the ...
...ar-old adults in UK revealed that above half of th.../ To make themselves intoxicate, about 18 per cent...ol. About 59 per cent and 43 per cent of people in...24 and 25-34 respectively, and who drank to get dr...
Other Medicine News:Health News:New Research May Be Useful for Developing Drugs for HIV and Cancer 2Health News:Ritalin Could Help In Focussing The Mind 2
All oral and nasal airways are manufactured with smooth, rounded edges for increased patient comfort and safety., ,Portex® offers a broad selection of airways for a variety of clinical applicati
Rsch color coded Guedel airways offer our best value on oropharyngeal airways. They uniquely combine color coding for size and flexible material without a premium price. Color coded airways are latex
Our soft guedel airway is clear and has a color coded bite block. Airway has a smooth finish and is Latex Free. Recommended for single use. Non-Sterile.
Rsch color coded Guedel airways offer our best value on oropharyngeal airways. They uniquely combine color coding for size and flexible material without a premium price. Color coded airways are latex
Medicine Products: